AstraZeneca (AZN) Reels from China Investigation and Investor Suit – Hagens Berman
01 janv. 2025 10h07 HE
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Jan. 01, 2025 (GLOBE NEWSWIRE) -- AstraZeneca, the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a series of...